Li Fang-Fei, Cui Yu-Sha, Yan Rui, Cao Shuang-Shuang, Feng Tao
Department of Neurology, Center for Movement Disorders, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
Front Aging Neurosci. 2022 Sep 12;14:977572. doi: 10.3389/fnagi.2022.977572. eCollection 2022.
Lower urinary tract symptoms (LUTS) are common non-motor symptoms but are often overlooked in Parkinson's disease (PD). The prevalence of LUTS in PD is inconsistent among different studies.
To estimate the prevalence of LUTS, urinary incontinence, and urinary retention in PD patients, then, investigate potential sources of inconsistency in prevalence estimation.
We searched PubMed, EMBASE, and Web of Science databases from inception to May 2022. Studies reporting the prevalence of LUTS or LUTS subtypes in PD were included. Pooled prevalence of LUTS, LUTS subtypes, urinary incontinence, and urinary retention was calculated random-effects models. Meta-regression and subgroup analyses were performed.
Of 7,358 studies after duplicate removal, a total of 73 studies comprising 14,937 PD patients were included. The pooled prevalence of LUTS was 61% (95% CI 53-69; 27 studies; = 5,179), while the pooled prevalence of storage symptoms and voiding symptoms was 59% (44-73; 9 studies; = 798) and 24% (14-33; 11 studies; = 886), respectively. The pooled prevalence of urinary incontinence, retention and post-void residual (PVR) volume ≥ 100 ml were 30% (95% CI 22-39; 21 studies; = 6,054), 27% (17-37; 14 studies; = 1,991), and 4% (1-7; 5 studies; = 439), respectively. The prevalence of LUTS, urinary incontinence, or urinary retention was significantly associated with diagnostic methods.
LUTS and its subtypes present in a significant proportion of PD patients. It is necessary to use standardized and validated methods to detect and screen LUTS and its subtypes. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022311233, Identifier: CRD42022311233.
下尿路症状(LUTS)是常见的非运动症状,但在帕金森病(PD)中常被忽视。不同研究中PD患者LUTS的患病率不一致。
估计PD患者中LUTS、尿失禁和尿潴留的患病率,然后调查患病率估计中潜在的不一致来源。
我们检索了从数据库建库至2022年5月的PubMed、EMBASE和Web of Science数据库。纳入报告PD患者中LUTS或LUTS亚型患病率的研究。采用随机效应模型计算LUTS、LUTS亚型、尿失禁和尿潴留的合并患病率。进行了Meta回归和亚组分析。
在去除重复研究后得到的7358项研究中,共纳入73项研究,涉及14937例PD患者。LUTS的合并患病率为61%(95%CI 53 - 69;27项研究;n = 5179),储尿期症状和排尿期症状的合并患病率分别为59%(44 - 73;9项研究;n = 798)和24%(14 - 33;11项研究;n = 886)。尿失禁、尿潴留和残余尿量≥100 ml的合并患病率分别为30%(95%CI 22 - 39;21项研究;n = 6054)、27%(17 - 37;14项研究;n = 1991)和4%(1 - 7;5项研究;n = 439)。LUTS、尿失禁或尿潴留的患病率与诊断方法显著相关。
相当比例的PD患者存在LUTS及其亚型。有必要使用标准化和经过验证的方法来检测和筛查LUTS及其亚型。https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022311233,标识符:CRD42022311233 。